The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University How different peptide therapies may affect your body Prenuvo blog FDA takes first step in possible reversal of ban on some peptides The Washington Post In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times